An observational study in Severe Mental Illness, sponsored by Medizinische Hochschule Brandenburg Theodor Fontane. Enrolling by invitation at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Medizinische Hochschule Brandenburg Theodor Fontane · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this observational study is to learn how patients with mental disorders use, perceive, and evaluate generative artificial intelligence (AI) chatbots for mental health-related purposes. The study aims to investigate usage patterns, expectations, experiences, perceived benefits, barriers, and concerns regarding AI chatbots among adults receiving psychiatric or psychotherapeutic treatment.
The main questions it aims to answer are:
Participants will:
There is no intervention, randomization, control group, or comparison arm in this study. The study follows a prospective cross-sectional mixed-methods design using quantitative survey data, qualitative free-text responses, and semi-structured interviews.
1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.
This study's planned enrollment of 150 is below the median of 220 across 391 observational studies indexed under Mental Disorders.
Browse Mental Disorders studies →Medizinische Hochschule Brandenburg Theodor Fontane is the lead sponsor of 17 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Psychiatric outpatient clinics, medical practices, and counseling centers in Berlin/Brandenburg
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Percentage of patients who have used generative AI for mental health issues
Time frame: up to 6 months
Started Jul 2026 (actual). Primary completion is estimated for Dec 2026, 5 months after the start.
Start moved once since we started tracking on Sep 25, 2026: Jun 2026 → Jul 2026, on Oct 8, 2026.
Primary completion moved twice since we started tracking on Sep 25, 2026: Aug 2026 → Dec 2026, last on Nov 16, 2026.
Completion moved once since we started tracking on Sep 25, 2026: Nov 2026 → Dec 2026, on Nov 16, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medizinische Hochschule Brandenburg Theodor Fontane